![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, September 19, 2003 7:57:25 PM
From a paper dated July 2003
These about licensing revenues from research
John Fraser, director of technology transfer at fourth-place Florida State University (FSU), says his school's $62.1 million in FY 2001 was almost entirely based on royalties from Bristol-Myers Squibb for exclusive use of a patented process to manufacture the anticancer drug Taxol. "For us this is a major blockbuster. It's just enormous," Fraser says. "It swamps anything else we've done."
Gone from 2001's top-10 life sciences technology list are Columbia University, the University of Pennsylvania, and Duke University. They were replaced in 2002 by the University of Michigan, University of Wisconsin, and Pennsylvania State University.
My comments
There is a huge amount of money in drug developement research
Shows we are working with some of the best minds in academia. GL2A
GE
FEATURED North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • Jul 18, 2024 9:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM